Intent to Award a Sole Source Contract: on a research project to explore advanced imaging technologies and AI assisted image analysis to facilitate product development and ANDA assessment of complex generics.

The Department of Health and Human Services Food and Drug Administration, specifically the Center for Drug Evaluation and Research, has issued a Special Notice announcing their intent to award a sole source contract for advanced imaging research. The contract will focus on exploring advanced imaging technologies and AI-assisted image analysis to facilitate product development and ANDA (Abbreviated New Drug Application) assessment of complex generics. This opportunity is classified under biotechnology research and development services and falls within the professional support category for program evaluation and development. The notice was posted on August 29, 2025, and includes a justification document for proceeding without full and open competition. The research initiative appears to involve sophisticated 3D microscopy and artificial intelligence-based quantification methods for pharmaceutical regulatory purposes.

The primary objective of this sole source procurement is to support the FDA's evaluation and regulatory oversight of complex generic drug products through cutting-edge imaging and AI technologies. Interested parties have until September 11, 2025, to respond to this notice, providing a brief two-week window for any potential engagement. Since this is designated as a sole source contract, the FDA has already identified a specific contractor they intend to work with, and the attached justification document explains their reasoning for not conducting full and open competition. The research will specifically focus on non-clinical evaluation methods and regulatory support mechanisms for complex drug products. The initiative represents the FDA's commitment to leveraging advanced technologies including 3D microscopy and artificial intelligence for enhanced pharmaceutical assessment capabilities. No set-aside designations apply to this opportunity, indicating it is open to contractors of all sizes, though the sole source nature limits actual competition.